BioLife Solutions, Inc.

BLFS · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$20-$66-$140-$8
Dep. & Amort.$5$12$16$13
Deferred Tax-$0-$0-$5-$20
Stock-Based Comp.$31$32$25$14
Change in WC$0$1-$15-$4
Other Non-Cash-$8$9$110-$0
Operating Cash Flow$8-$12-$8-$5
Investing Activities
PP&E Inv.-$3-$6-$10-$8
Net Acquisitions$60$0$0$2
Inv. Purchases-$18-$27-$53-$6
Inv. Sales/Matur.$22$56$9$6
Other Inv. Act.-$2-$5-$4-$6
Investing Cash Flow$58$18-$58-$13
Financing Activities
Debt Repay.-$7-$0$18-$3
Stock Issued$0$10$0$1
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$1-$2-$1
Financing Cash Flow-$7$11$16-$3
Forex Effect$0$0-$0-$0
Net Chg. in Cash$60$16-$50-$21
Supplemental Information
Beg. Cash$35$19$70$90
End Cash$95$35$19$70
Free Cash Flow$5-$19-$19-$13
BioLife Solutions, Inc. (BLFS) Financial Statements & Key Stats | AlphaPilot